This application is to add a Neuroimaging Core to the Indiana Alzheimer's Disease Center (ADC). The new IU Center for Neuroimaging and the evolution and needs of scientific projects related to the ADC makes this an ideal time. Several driving themes guide the proposed core including the importance of imaging as an in- vivo window to neuropathological processes that aids detection during preclinical stages and as a biomarker for treatment response. The integration of imaging and genetics is an important new transdisciplinary direct- ion with great promise for assessing candidate genes and discovery of new molecular mechanisms. There is also great potential for translational imaging research with common methodology across clinical studies and animal models. New collaborative teams and educational opportunities are also critical. The overarching goal is to support advanced neuroimaging technology and scientific collaboration for clinical and translational research studies within the Indiana ADC and to serve as a regional resource to the research community.
Specific Aims : (I) Provide standardized, state-of-the-art structural, functional and molecular neuroimaging acquisition and analysis protocols for ADC-affiliated research programs and beyond;(II) Support research in the ADC, ID Center for Aging, and related programs that currently employs or could benefit from advanced neuroimaging;(III) Expand and support research using imaging tools to study neurodegenerative disease mechanisms and treatments;and (IV) Provide educational opportunities in neuroimaging and genetics of AD and other degenerative disorders to scientists at all career stages from undergraduates to faculty. The core will expand the scientific value of outstanding research programs on campus as well as contribute to several national initiatives on dementia including ADNI. Examples of ADC related projects that will greatly benefit from the proposed core include multiple family studies of hereditary dementias and related transgenic animal models developed by ADC investigators, the Indianapolis African-American Health and Aging Cohort, several MCI related R01 projects, and programs of the Center for Aging. This Core will foster the development of research employing brain imaging that will create important new knowledge regarding dementia.

Public Health Relevance

Alzheimer's disease is a highly prevalent aging-related brain disorder with tremendous cost to patients, family members, society and the economy. Neuroscience research on the mechanisms that cause AD and other dementias is essential for the development of effective treatments and ultimately for prevention. Advanced brain imaging can greatly facilitate this research which is highly important for public health.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG010133-18S1
Application #
7567799
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Silverberg, Nina B
Project Start
1997-07-15
Project End
2011-06-30
Budget Start
2009-05-15
Budget End
2009-06-30
Support Year
18
Fiscal Year
2009
Total Cost
$75,505
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pathology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Groveman, Bradley R; OrrĂ¹, Christina D; Hughson, Andrew G et al. (2018) Rapid and ultra-sensitive quantitation of disease-associated ?-synuclein seeds in brain and cerebrospinal fluid by ?Syn RT-QuIC. Acta Neuropathol Commun 6:7
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Zigon, Bob; Li, Huang; Yao, Xiaohui et al. (2018) GPU Accelerated Browser for Neuroimaging Genomics. Neuroinformatics 16:393-402
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Mustafa, Rafid; Brosch, Jared R; Rabinovici, Gil D et al. (2018) Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging. Alzheimer Dis Assoc Disord 32:35-42

Showing the most recent 10 out of 604 publications